FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$162M
2
+$79.3M
3
+$78.5M
4
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$75.1M
5
KRYS icon
Krystal Biotech
KRYS
+$57.6M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$162M 13.84%
+8,434,232
2
$79.3M 6.76%
+5,827,415
3
$78.5M 6.69%
+3,566,912
4
$75.1M 6.4%
+2,342,198
5
$57.6M 4.91%
+866,250
6
$57.3M 4.88%
+2,971,274
7
$55.8M 4.75%
+2,309,554
8
$55.5M 4.73%
+3,195,403
9
$44.4M 3.78%
+2,712,041
10
$40.8M 3.47%
+2,421,563
11
$37.5M 3.2%
+4,185,757
12
$32.2M 2.74%
+1,739,530
13
$31.1M 2.65%
+1,414,823
14
$26.5M 2.26%
+603,521
15
$23.8M 2.03%
+1,417,157
16
$23.2M 1.98%
+1,572,192
17
$22.3M 1.9%
+899,700
18
$21.6M 1.84%
+5,237,348
19
$19.9M 1.69%
+2,651,754
20
$18.2M 1.55%
+270,331
21
$17.1M 1.46%
+2,082,093
22
$16.7M 1.43%
+881,173
23
$16.6M 1.42%
+628,979
24
$15.6M 1.33%
+3,746,857
25
$15.5M 1.32%
+250,461
1
2